These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3879505)

  • 21. [Clinical significance of serum complement investigation].
    Teisberg P
    Tidsskr Nor Laegeforen; 1974 Jan; 94(1):24-9. PubMed ID: 4595244
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum complement in chronic active glomerulonephritis].
    Todesco S; Castellani A; Gambari PF; Toso M
    Boll Soc Ital Biol Sper; 1967 Nov; 43(22):1536-40. PubMed ID: 4876112
    [No Abstract]   [Full Text] [Related]  

  • 23. The difference between serum and plasma complement activity in primary renal disease.
    Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
    Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of serum complement in the hypocomplementaemic nephritides.
    Williams DG; Peters DK; Fallows J; Petrie A; Kourilsky O; Morel-Maroger L; Cameron JS
    Clin Exp Immunol; 1974 Nov; 18(3):391-405. PubMed ID: 4219908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement studies in BN rats with mercuric chloride-induced immune glomerulonephritis.
    Capron M; Ayed K; Druet E; Sapin C; Mandet C; Druet P; Girard JF
    Ann Immunol (Paris); 1980; 131D(1):43-55. PubMed ID: 7436354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA; Morris SM; Dash A; Peters DK
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
    Cojocaru M; Serbănescu A; Cojocaru IM
    Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An improved sensitive and simple microassay of mouse complement.
    De Waal RM; Schrijver G; Bogman MJ; Assmann KJ; Koene RA
    J Immunol Methods; 1988 Apr; 108(1-2):213-21. PubMed ID: 3127471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
    Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical course of lupus nephritis: relationship to the renal histologic findings.
    Pollak VE; Pirani CL; Dujovne I; Dillard MG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    Gilliam JN; Cheatum DE; Hurd ER; Stastny P; Ziff M
    J Clin Invest; 1974 May; 53(5):1434-40. PubMed ID: 4596508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Optimization of a method for determination of complement activity from 50% hemolysis of sensibilized red blood cells].
    Tikhomirova TA; Lapin SV; Neustroeva IuA; Totolian AA
    Klin Lab Diagn; 2006 May; (5):46-50. PubMed ID: 16827241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
    Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
    Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of complement values in calves during the first month of life.
    Mueller R; Boothby JT; Carroll EJ; Panico L
    Am J Vet Res; 1983 May; 44(5):747-50. PubMed ID: 6869976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automation of immune hemolytic and complement reactions by AutoAnalyzer. II.
    Vargues R; Henley W
    Mt Sinai J Med; 1974; 41(3):453-79. PubMed ID: 4134099
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.
    West CD; Winter S; Forristal J; McConville JM; Davis NC
    J Clin Invest; 1967 Apr; 46(4):539-48. PubMed ID: 4164258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lupus nephritis: immunofluorescence study of 54 cases.
    Morel-Maroger L; Méry JP; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1183-6. PubMed ID: 4610502
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rapid micromethod for CH50 determination using an algorithm].
    Allal C; Toumi A; Chelah A; Merahba H; Abbadi MC
    Arch Inst Pasteur Alger; 1992; 58():299-306. PubMed ID: 1309145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.